Article
Ligand-independent phosphorylation of Y869 (Y845) links mutant EGFR signaling to stat-mediated gene expression.
Experimental cell research - 15 Jan 2008
Yang Seungchan, Park Kyungho, Turkson James, Arteaga Carlos L
Abstract excerpt
Activating mutants of EGFR have been identified in a subset of non-small-cell lung cancers. To investigate mutant-driven signaling, we focused on Y869, a residue in the same activation loop where the L858R and L861Q mutations are located. We observed ligand-independent phosphorylation of Y869 in 32D cells EGFR(L858R) and EGFR(L861Q). The EGFR tyrosine kinase inhibitor (TKI) erlotinib inhibited Y869 P-EGFR in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
